BnR Summit 2025

Belt and Road Summit 2025- Deal-making

10 – 16 Sept 2025 | China (Hong Kong)

ProjectUpdated on 28 August 2025

KetoAir Global Expansion: Seeking Distribution Partners for Revolutionary Breath Health Monitoring

Nelson Yiu

Ecommerce and Business Development Manager at Qi Diagnostics Limited

Hong Kong, China (Hong Kong)

About

KetoAir by Qi Diagnostics Limited offers revolutionary breath-based health monitoring technology seeking strategic distribution partners across Belt & Road Initiative countries.

Our Innovation:
FDA Class I medical device clearance for non-invasive ketone monitoring through proprietary nanosensor technology. KetoAir delivers clinical-grade accuracy in just 20 seconds, eliminating painful blood testing for ketogenic dieters, diabetics, and health-conscious consumers.

Proven Market Success:

  • 6 international patents in breath diagnostics

  • HKMA/HKT Global Innovation Award 2024/25 winner

  • Established North American and European distribution through NASDAQ-listed Avalon GloboCare Corp

  • Successfully launched in US market 2024

Partnership Opportunities:

  • Exclusive regional distribution rights

  • Joint venture manufacturing agreements

  • Healthcare system integration partnerships

  • Technology licensing for local adaptation

Target Markets:
Rising diabetes epidemic and ketogenic diet popularity create massive opportunity across Belt & Road countries' expanding middle-class populations seeking preventive healthcare solutions.

Ready for Immediate Deployment:
Proven technology, established supply chains, and regulatory expertise supporting rapid regional expansion with the right strategic partners.

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Operations

Main Project Sector

  • Manufacturing
  • Technology

Technology

  • Bio-Tech
  • Health Technology
  • Medical Technology

Preferred Financing Model

  • Open for negotiation

Previous Funding Stage

  • IPO

Main Service(s) Required

  • Financial Services
  • Professional Services

Professional Services

  • Corporate Intelligence
  • Financial Advisory
  • Market Entry Strategic Analysis
  • Tax Advisory

Organisation

Qi Diagnostics Limited

Hong Kong, China (Hong Kong)

Similar opportunities